» Authors » Parvin Zakeri-Milani

Parvin Zakeri-Milani

Explore the profile of Parvin Zakeri-Milani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 112
Citations 1163
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Krabicova I, Khazaei Monfared Y, Caldera F, Mahmoudian M, Hobbs C, Santalucia R, et al.
Int J Mol Sci . 2025 Feb; 26(3). PMID: 39940979
Cholesterol, the essential building block of cellular membranes, has proven to be a useful tool for increasing the biocompatibility and bioavailability of drug delivery systems in cancer treatment. Resveratrol, a...
2.
Mahmoudian M, Alizadeh S, Lotfi D, Khazaei Monfared Y, Mahdipour M, Trotta F, et al.
Nanotoxicology . 2024 Dec; 19(1):17-27. PMID: 39727335
The cellular components of the tumor microenvironment (TME) comprise cancer cells and nonmalignant cells including stromal and immune cells. Exosomes are extracellular vesicles secreted by various types of cells that...
3.
Zahednezhad F, Allahyari S, Sarfraz M, Zakeri-Milani P, Feyzizadeh M, Valizadeh H
Expert Opin Drug Deliv . 2024 Sep; 21(9):1363-1384. PMID: 39282895
Introduction: Targeted liposomal systems for cancer intention have been recognized as a specific and robust approach compared to conventional liposomal delivery systems. Cancer cells have a unique microenvironment with special...
4.
Shakouei S, Ghasemi N, Zakeri-Milani P, Shahali A, Alipour M
Biomater Investig Dent . 2024 Jul; 11:41069. PMID: 39070047
Objective: This study evaluated the sealing ability of different biomaterials as intra-orifice barriers in the internal bleaching of discolored teeth with the walking bleaching technique. The release of hydroxyl ions...
5.
Khaleseh F, Barzegar-Jalali M, Zakeri-Milani P, Karami Z, Saghatchi Zanjani M, Valizadeh H
Iran J Basic Med Sci . 2024 May; 27(7):857-867. PMID: 38800017
Objectives: Lipid-based drug delivery systems (DDS) can improve the pharmacokinetic (PK) parameters of some drugs. Especially those with a high volume of distribution (Vd) leading to off-target accumulation and toxicity....
6.
Mostafaei F, Hemmati S, Valizadeh H, Mahmoudian M, Sarfraz M, Abdi M, et al.
Int J Pharm . 2023 Nov; 649:123635. PMID: 38000649
Asialoglycoprotein receptors (ASGPRs) are highly expressed on hepatocytes and have been used for liver-targeted delivery and hepatocellular carcinoma (HCC) therapy. However, targeted delivery of bortezomib (BTZ) to HCC has not...
7.
Mostafaei F, Mahdinloo S, Valizadeh H, Hemmati S, Abdi M, Sarfraz M, et al.
Nanomedicine (Lond) . 2023 Nov; 18(25):1855-1873. PMID: 37991168
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, typically diagnosed in advanced stages. Chemotherapy is necessary for treating advanced liver cancer; however, several challenges affect its...
8.
Valizadeh H, Mahdinloo S, Zakeri N, Sarfraz M, Nezafat S, Zakeri-Milani P
Adv Pharm Bull . 2023 Aug; 13(3):532-538. PMID: 37646059
Purpose: Poor aqueous solubility hampers the development of several compounds as pharmacological agents. Hence, preparing novel formulations with augmented absorption is a challenge in pharmaceutical industries. In this paper, we...
9.
Khazaei Monfared Y, Mahmoudian M, Zakeri-Milani P, Cecone C, Hayashi T, Ishii K, et al.
Cancers (Basel) . 2023 Jul; 15(14). PMID: 37509409
mRNA technology has demonstrated potential for use as an effective cancer immunotherapy. However, inefficient in vivo mRNA delivery and the requirements for immune co-stimulation present major hurdles to achieving anti-tumour...
10.
Seify R, Zahednezhad F, Zakeri-Milani P, Valizadeh H
Drug Dev Ind Pharm . 2023 May; 49(5):367-376. PMID: 37249553
Objective: This study was intended to explore and evaluate the appropriate methods for preparation of Amphotericin B (AmB) liposomes with acceptable characteristics. Significance: This project provides pre-formulations for industrial manufacturing...